We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · September 03, 2020

Rucaparib in Metastatic Castration-Resistant Prostate Cancer With BRCA1/2 Alteration

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration
J. Clin. Oncol 2020 Aug 14;[EPub Ahead of Print], W Abida, A Patnaik, D Campbell, J Shapiro, AH Bryce, R McDermott, B Sautois, NJ Vogelzang, RM Bambury, E Voog, J Zhang, JM Piulats, CJ Ryan, AS Merseburger, G Daugaard, A Heidenreich, K Fizazi, CS Higano, LE Krieger, CN Sternberg, SP Watkins, D Despain, AD Simmons, A Loehr, M Dowson, T Golsorkhi, S Chowdhury

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Advanced Prostate Cancer Center of Excellence

Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.


Further Reading